Natural Product: NPC482045

Natural Product IDNPC482045
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
OOQZCQKEFKRXLR-UECATJJXSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 44587481
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OOQZCQKEFKRXLR-UECATJJXSA-N
Standard InCHI InChI=1S/C24H32O4/c1-18(2)7-5-8-19(3)9-6-10-20(4)15-16-28-24(27)14-12-21-11-13-22(25)23(26)17-21/h7,9,11-15,17,25-26H,5-6,8,10,16H2,1-4H3/b14-12+,19-9-,20-15-
SMILES CC(=CCC/C(=CCC/C(=CCOC(=O)/C=C/c1ccc(c(c1)O)O)/C)/C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   384.23 Volume:   429.173
?
Van der Waals volume.
Dense:   0.895 LogP:   7.126
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.987
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.397
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   11.0
TPSA:   66.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   2.0 Rings:   1.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.222 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.857 Fsp3:   0.375
MCE-18:   10.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.999 Fluc inhibitor:   0.996
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.246
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.514
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.683 Promiscuous compounds:   0.312

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.939 MDCK Permeability:   -4.719
Pgp-inhibitor:   0.792 Pgp-substrate:   0.013
PAMPA:   0.01
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.024
20% Bioavailability (F20%):   0.953 30% Bioavailability (F30%):   0.981
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.27 MRP1:   0.979
Plasma Protein Binding (PPB):   96.36% Volume Distribution (VD):   -0.132
Fu: 4.046%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.961
OATP1B3 inhibitor:   0.956 BCRP inhibitor:   0.084
BSEP inhibitor:   0.935

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.12
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.008
CYP2C9-inhibitor:   0.013 CYP2C9-substrate:   0.027
CYP2D6-inhibitor:   0.27 CYP2D6-substrate:   0.831
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.986
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  14.565 Half-life (T1/2):  1.156

ADMET: Toxicity

hERG Blockers:  0.12 hERG Blockers (10um):  0.717
Human Hepatotoxicity (H-HT):  0.376 Drug-induced Liver Injury (DILI):  0.039
AMES Toxicity:  0.147 Rat Oral Acute Toxicity:  0.025
Maximum Recommended Daily Dose:  0.281 Skin Sensitization:  1.0
Carcinogencity:  0.127 Eye Corrosion:  0.273
Eye Irritation:  0.987 Respiratory Toxicity:  0.278
Drug-induced Neurotoxicity:  0.203 Ototoxicity:  0.482
Hematotoxicity:  0.054 Drug-induced Nephrotoxicity:  0.146
Genotoxicity:  0.008 RPMI-8226 Immunitoxicity:  0.013
A549 Cytotoxicity:  0.224 Hek293 Cytotoxicity:  0.079
BCF:   1.643
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.146
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.869
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.423
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40119 Eremophila longifolia Species Scrophulariaceae Eukaryota n.a. n.a. n.a. PMID[28257200]
NPO40119 Eremophila longifolia Species Scrophulariaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell line RAW264.7 Mus musculus Ratio EC50 = 10.3 n.a. PMID[18667320]
NPT113 Cell line RAW264.7 Mus musculus EC50 = 2658.0 nM PMID[18667320]
NPT113 Cell line RAW264.7 Mus musculus EC50 = 258.0 nM PMID[18667320]
NPT171 Cell line MRC5 Homo sapiens IC50 = 13.3 ug.mL-1 PMID[28257200]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 0.23 ug.mL-1 PMID[28257200]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC482045 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8039 Intermediate Similarity NPC482044
0.7551 Intermediate Similarity NPC261453
0.6949 Remote Similarity NPC482043
0.6923 Remote Similarity NPC271641
0.6226 Remote Similarity NPC33749
0.62 Remote Similarity NPC95381
0.6 Remote Similarity NPC328593
0.5926 Remote Similarity NPC474967
0.5789 Remote Similarity NPC203124
0.5789 Remote Similarity NPC607366
0.5758 Remote Similarity NPC30174
0.5556 Remote Similarity NPC217472
0.5536 Remote Similarity NPC147654
0.5424 Remote Similarity NPC65791
0.5345 Remote Similarity NPC263386
0.5345 Remote Similarity NPC141791
0.5333 Remote Similarity NPC204466
0.5294 Remote Similarity NPC226250
0.52 Remote Similarity NPC197467
0.5094 Remote Similarity NPC304638
0.5088 Remote Similarity NPC233669
0.5085 Remote Similarity NPC18646

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC482045 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5192 Remote Similarity NPD6927 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data